Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial - Granger, C B; Lopes, R D; Hanna, M (Am Heart J, 2015)
, et al.